rolipram has been researched along with Rheumatoid Arthritis in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We assessed the anti-inflammatory effects of a novel PDE4 inhibitor, apremilast, in human synovial cells from rheumatoid arthritis (RA) patients, as well as two murine models of arthritis." | 3.76 | Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis. ( Andrews, M; Brennan, FM; Feldmann, M; Inglis, JJ; McCann, FE; Palfreeman, AC; Perocheau, DP; Schafer, P; Williams, RO, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McCann, FE | 1 |
| Palfreeman, AC | 1 |
| Andrews, M | 1 |
| Perocheau, DP | 1 |
| Inglis, JJ | 1 |
| Schafer, P | 1 |
| Feldmann, M | 2 |
| Williams, RO | 3 |
| Brennan, FM | 2 |
| Ozegbe, P | 1 |
| Foey, AD | 2 |
| Ahmed, S | 2 |
| Field, S | 1 |
| Jain, A | 1 |
| Williams, R | 1 |
| Singh, HN | 1 |
| Blancuzzi, V | 1 |
| Greenwood, S | 1 |
| Skiles, JW | 1 |
| O'Byrne, EM | 1 |
| Kitagawa, M | 1 |
| Mitsui, H | 1 |
| Nakamura, H | 1 |
| Yoshino, S | 1 |
| Miyakawa, S | 1 |
| Ochiai, N | 1 |
| Onobori, M | 1 |
| Suzuki, H | 1 |
| Sumida, T | 1 |
| Dal Piaz, V | 1 |
| Giovannoni, MP | 1 |
| Eigler, A | 1 |
| Loher, F | 1 |
| Endres, S | 1 |
3 reviews available for rolipram and Rheumatoid Arthritis
| Article | Year |
|---|---|
Combination therapy in mice: what can we learn that may be useful for understanding rheumatoid arthritis?
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibody Specificity; Anti | 1998 |
Phosphodiesterase 4 inhibitors, structurally unrelated to rolipram, as promising agents for the treatment of asthma and other pathologies.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Arthritis, Rheumatoid; Asthma; Cyclic Nucleotide Phosphodiester | 2000 |
[Suppression of synthesis of tumor necrosis factor].
Topics: Animals; Arthritis, Rheumatoid; Crohn Disease; Humans; Inflammation; Interleukin-10; Phosphodiestera | 2001 |
5 other studies available for rolipram and Rheumatoid Arthritis
| Article | Year |
|---|---|
Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Cells, Cultured; Disease Models, Animal; Do | 2010 |
Impact of cAMP on the T-cell response to type II collagen.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antigen-Presenting Cells; Arthritis, Experimental; | 2004 |
Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Arthritis, Rheumatoid; Bucladesine; Cells, Cultured; Colforsin; | 2003 |
Synovial fluid levels of tumor necrosis factor-alpha in the inflamed rat knee: modulation by dexamethasone and inhibitors of matrix metalloproteinase and phosphodiesterase.
Topics: Animals; Arthritis, Rheumatoid; Dexamethasone; Female; Kinetics; Lipopolysaccharides; Metalloendopep | 1997 |
Differential regulation of rheumatoid synovial cell interleukin-12 production by tumor necrosis factor alpha and CD40 signals.
Topics: Adjuvants, Immunologic; Antibodies; Antigens, Differentiation, T-Lymphocyte; Arthritis, Rheumatoid; | 1999 |